XML 32 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 13 - Stock-based Compensation
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(
13
)
Stock-Based Compensation
 
The fair value of all awards granted, net of estimated forfeitures, is recognized as compensation expense over the respective service period.
 
Bancorp currently has
one
stock-based compensation plan. At Bancorp's
2015
Annual Meeting of Shareholders, shareholders approved the
2015
Omnibus Equity Compensation Plan and authorized the shares available from the expiring
2005
plan for future awards under the
2015
plan. The
2005
Stock Incentive Plan expired in
April 2015;
however,
500
thousand additional shares were made available in the
second
quarter of
2018.
SARs granted under this plan expire as late as
2025.
As of
September 30, 2018,
there were
696,711
shares available for future awards.
 
Options, which have
not
been granted since
2007,
generally had a vesting schedule of
20%.
The last remaining options were exercised in the
first
quarter of
2017.
 
Stock appreciation rights (“SARs”) granted have a vesting schedule of
20%
per year and expire
ten
years after the grant date unless forfeited due to employment termination. Fair values are determined using the Black Scholes pricing model as described later in this foot note.
 
Restricted shares granted to officers vest over
five
years. For all grants prior to
2015,
grantees are entitled to dividend payments during the vesting period. For grants in
2015
and forward, forfeitable dividends are deferred until shares are vested. Fair value of restricted shares is equal to the market value of the shares on the date of grant.
 
Grants of performance stock units (“PSUs”) vest based upon a single
three
-year performance period which begins
January 1
of the
first
year of the performance period. Because grantees are
not
entitled to dividend payments during the performance period, the fair value of these PSUs is estimated based upon the fair value of the underlying shares on the date of grant, adjusted for non-payment of dividends. Grants require a
one
year post-vesting holding periods and the fair value of such grants incorporates a liquidity discount related to the holding period of
4.26%,
5.12%
and
4.50%
for
2018,
2017,
and
2016,
respectively.
 
Grants of restricted stock units (“RSUs”) to directors are time-based and vest
12
months after grant date. Because grantees are entitled to deferred dividend payments at the end of the vesting period, fair value of the RSUs is estimated based on fair value of underlying shares on the date of grant.
 
Bancorp has recognized stock-based compensation expense, within salaries and employee benefits for employees, and within other non-interest expense for directors, in the consolidated statements of income as follows: 
 
   
For three months ended
   
For nine months ended
 
   
September 30,
   
September 30,
 
(In thousands)
 
2018
   
2017
   
2018
   
2017
 
Stock-based compensation expense before income taxes
  $
887
    $
670
    $
2,923
    $
2,012
 
Less: deferred tax benefit
   
(186
)    
(235
)    
(614
)    
(704
)
Reduction of net income
  $
701
    $
435
    $
2,309
    $
1,308
 
 
Bancorp expects to record an additional
$877
thousand of stock-based compensation expense in
2018
for equity grants outstanding as of
September 30, 2018.
As of
September 30, 2018,
Bancorp has
$5.9
million of unrecognized stock-based compensation expense that is expected to be recorded as compensation expense over the next
five
years as awards vest. Bancorp used cash of
$154
thousand during the
first
nine
months of
2018
for the purchase of shares upon the vesting of restricted stock units. This compares with cash used of
$216
thousand during the
first
nine
months of
2017
for the purchase of shares upon the vesting of restricted stock units net of cash received for options exercised.
 
Fair values of Bancorp’s SARs are estimated at the date of grant using the Black-Scholes option pricing model, a leading formula for calculating the value of stock options and SARs. This model requires use of assumptions, changes to which can materially affect the fair value estimate. The following assumptions were used in SAR valuations at the grant date in each year:
 
 
   
2018
   
2017
 
                 
Dividend yield
   
2.57
%    
2.72
%
Expected volatility
   
20.60
%    
19.47
%
Risk free interest rate
   
2.82
%    
2.29
%
Expected life of SARs (in years)
   
7.0
     
7.0
 
 
 
Dividend yield and expected volatility are based on historical information for Bancorp corresponding to the expected life of options and SARs granted. Expected volatility is the volatility of the underlying shares for the expected term on a monthly basis. The risk free interest rate is the implied yield currently available on U.S. Treasury issues with a remaining term equal to the expected life of the options. The expected life of SARs is based on actual experience of past like-term SARs. Bancorp evaluates historical exercise and post-vesting termination behavior when determining the expected life.
 
A summary of stock option and SARs activity and related information for the
twelve
month period ended
December 31, 2017
and the
nine
month period ended
September 30, 2018
follows:
 
   
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted
 
   
 
 
 
 
 
 
 
 
 
 
Weighted
   
Aggregate
   
Weighted
   
average
 
   
Options
   
 
 
 
 
 
 
average
   
intrinsic
   
average
   
remaining
 
   
and SARs
   
Exercise
   
exercise
   
value
   
fair
   
contractual
 
   
(In thousands)
   
price
   
price
   
(In thousands)
   
value
   
life (In years)
 
                                                     
At December 31, 2016
                                                   
Vested and exercisable
   
475
    $
14.02
-
24.56
    $
15.72
    $
14,820
    $
3.16
     
4.3
 
Unvested
   
260
     
15.24
-
33.08
     
21.53
     
6,623
     
3.43
     
7.8
 
Total outstanding
   
735
     
14.02
-
33.08
     
17.78
     
21,443
     
3.26
     
5.5
 
                                                     
                                                     
Granted
   
46
     
40.00
-
40.00
     
40.00
     
-
     
6.34
     
 
 
Exercised
   
(77
)    
14.02
-
17.89
     
15.41
     
1,855
     
3.18
     
 
 
Forfeited
   
-
     
 
 
-
     
-
     
-
     
-
     
 
 
                                                     
At December 31, 2017
                                                   
Vested and exercisable
   
490
     
14.02
-
33.08
     
16.46
     
10,408
     
3.16
     
4.0
 
Unvested
   
214
     
15.26
-
40.00
     
26.46
     
2,515
     
4.17
     
7.7
 
Total outstanding
   
704
     
14.02
-
40.00
     
19.51
     
12,923
     
3.47
     
5.1
 
                                                     
                                                     
Granted
   
47
     
35.90
-
38.85
     
36.01
     
18
     
6.67
     
 
 
Exercised
   
(65
)    
14.02
-
19.37
     
15.39
     
1,525
     
3.41
     
 
 
Forfeited
   
-
     
 
 
-
     
-
     
-
     
-
     
 
 
                                                     
At September 30, 2018
                                                   
Vested and exercisable
   
500
     
14.02
-
40.00
     
17.64
     
9,363
     
3.22
     
4.0
 
Unvested
   
187
     
19.37
-
40.00
     
30.14
     
1,293
     
4.97
     
7.8
 
Total outstanding
   
687
     
14.02
-
40.00
     
21.04
     
10,656
     
3.70
     
5.0
 
                                                     
Vested year-to-date
   
75
    $
15.26
-
40.00
    $
23.35
    $
1,006
    $
3.77
     
 
 
 
 
Intrinsic value for stock options and SARs is defined as the amount by which the current market price of the underlying stock exceeds the exercise
or
grant price.
 
A summary of activity for the
twelve
month period ending
December 31, 2017
and the
nine
month period ending
September 30, 2018
for restricted shares of common stock granted to officers is in the following table:
 
   
 
 
 
 
Grant date
 
   
 
 
 
 
weighted-
 
   
Number
   
average cost
 
Unvested at December 31, 2016
   
145,235
    $
21.57
 
Shares awarded
   
28,625
     
44.85
 
Restrictions lapsed and shares released
   
(46,797
)    
19.79
 
Shares forfeited
   
(7,691
)    
25.18
 
Unvested at December 31, 2017
   
119,372
     
27.62
 
                 
Shares awarded
   
38,680
     
36.03
 
Restrictions lapsed and shares released
   
(44,372
)    
23.58
 
Shares forfeited
   
(4,637
)    
30.93
 
Unvested at September 30, 2018
   
109,043
    $
32.10
 
 
 
Bancorp awarded performance-based restricted stock units (“PSUs”) to executive officers of Bancorp, the single
three
-year performance period for which began
January 1
of the award year. The following table outlines the PSU grants.
 
   
Vesting
   
 
 
 
 
Expected
 
Grant
 
period
   
Fair
   
shares to
 
year
 
in years
   
value
   
be awarded
 
2016
   
3
    $
22.61
     
69,161
 
2017
   
3
     
35.66
     
61,893
 
2018
   
3
     
31.54
     
50,352
 
 
 
In the
first
quarter of
2018,
Bancorp awarded
6,525
RSUs to directors of Bancorp with a grant date fair value of
$247
thousand.